Results per Page:
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
Altering a worm’s diet gives insight into a rare genetic disorder affecting proteasome function
From the Lehrbach Lab, Basic Sciences Division
Curiosity, connection and C. elegans
How a Fred Hutch worm study gives hope to families affected by an extremely rare genetic disorder
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
A look at emerging sickle cell disease therapies
Teams at the University of Washington School of Pharmacy and Fred Hutch will model the clinical and economic burden of sickle cell disease and the potential benefits of emerging therapies
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy